<DOC>
	<DOCNO>NCT00918554</DOCNO>
	<brief_summary>The purpose study determine whether methotrexate effective corticosteroid spar agent treatment sarcoid-associated uveitis .</brief_summary>
	<brief_title>Efficacy Study Methotrexate Treat Sarcoid-associated Uveitis</brief_title>
	<detailed_description>Macular oedema remain significant cause blindness . Corticosteroids effective treatment sarcoid-associated macular oedema 50 % relapse occur corticosteroid taper . Methotrexate ( MTX ) low dose show effective safe steroid-sparing agent lung sarcoidosis compilation report small series patient sarcoid-associated uveitis suggest 25 % relapse could achieve low dose MTX . We decide therefore test clinical efficacy MTX sarcoid-associated uveitis .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<criteria>Patients 18 year old Provided write consent participation trial prior studyspecific procedure requirement Posterior uveitis panuveitis associate macular oedema define increased macular thickness ( 250 mm assess Stratus TDOCT 300 mm Cirrus SDOCT ) and/or presence cystoid space macula , absence epiretinal membrane . Patient oral contraception Posterior uveitis panuveitis associate macular oedema Patients histologically proven sarcoidosis presume sarcoidosis . In case non caseate granuloma biopsy tissue , patient presume sarcoidosis meet least 2 4 follow criterion : typical change chest radiography compute tomography ; predominantly CD4 lymphocytosis bronchoalveolar lavage ( BAL ) fluid ; elevate serum ACE level ; elevate gallium 5 fluorodeoxyglucose uptake Patients fulfill inclusion criterion Other cause uveitis Extra ophthalmologic manifestation sarcoidosis justify corticosteroid Patients previously treat immunosuppressive agent corticosteroid 10 mg daily 15 day . Patients lifethreatening condition Chronic hepatopathy renal failure Uncontrolled diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Sarcoid-associated uveitis</keyword>
	<keyword>Macular oedema</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Conventional corticosteroid spar agent .</keyword>
</DOC>